世界の制限エンドヌクレアーゼ市場レポート2020年

【英語タイトル】Global Restriction Endonucleases Sales Market Report 2020

QYResearchが出版した調査資料(QYR21FB12322)・商品コード:QYR21FB12322
・発行会社(調査会社):QYResearch
・発行日:2021年1月(※2024年版があります。お問い合わせください)
・ページ数:132
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界の制限エンドヌクレアーゼ市場について種類別(タイプI、タイプII、タイプIII、タイプIV、その他)、用途別(学術・研究機関、病院・診断センター、バイオ医薬品、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・制限エンドヌクレアーゼ市場の概要
・世界の主要地域別制限エンドヌクレアーゼ市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の制限エンドヌクレアーゼ市場規模2015-2026:種類別(タイプI、タイプII、タイプIII、タイプIV、その他)
・世界の制限エンドヌクレアーゼ市場規模2015-2026:用途別(学術・研究機関、病院・診断センター、バイオ医薬品、その他)
・制限エンドヌクレアーゼのアメリカ市場規模2015-2020
・制限エンドヌクレアーゼのヨーロッパ市場規模2015-2020
・制限エンドヌクレアーゼの中国市場規模2015-2020
・制限エンドヌクレアーゼの日本市場規模2015-2020
・制限エンドヌクレアーゼの東南アジア市場規模2015-2020
・制限エンドヌクレアーゼのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・制限エンドヌクレアーゼの製造コスト分析
・販売チャネル、流通業者、顧客
・制限エンドヌクレアーゼの市場動向・機会・課題
・調査の結論
【レポートの概要】

Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.
Till date more than 10,000 bacteria are screened for the presence of restriction enzymes and currently there are more than 2,500 restriction enzymes have been discovered along with over 250 distinct specificities in sequences. These enzymes are used in conventional cloning, deciphering epigenetic modifications, construction of DNA libraries and in vivo gene editing. The end users mainly are Academic & Research Institutes, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology companies.

Market Analysis and Insights: Global Restriction Endonucleases Market
The global Restriction Endonucleases market size is projected to reach US$ 357.4 million by 2026, from US$ 254.8 million in 2020, at a CAGR of 5.8% during 2021-2026.

Global Restriction Endonucleases Scope and Market Size
The global Restriction Endonucleases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Restriction Endonucleases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Restriction Endonucleases market is segmented into
Type I
Type II
Type III
Type IV
Others

Segment by Application, the Restriction Endonucleases market is segmented into
Academic & Research Institutes
Hospitals & Diagnostic Centers
Biopharmaceutical
Other

The Restriction Endonucleases market is analysed and market size information is provided by regions (countries). Segment by Application, the Restriction Endonucleases market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Restriction Endonucleases Market Share Analysis
Restriction Endonucleases market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Restriction Endonucleases business, the date to enter into the Restriction Endonucleases market, Restriction Endonucleases product introduction, recent developments, etc.

The major vendors covered:
New England Biolabs
Thermo Fisher Scientific
Takara Bio
Illumina
Agilent Technologies
Roche
GE Healthcare
Promega Corporation
Qiagen
Jena Biosciences

【レポートの目次】

1 Restriction Endonucleases Market Overview
1.1 Restriction Endonucleases Product Scope
1.2 Restriction Endonucleases Segment by Type
1.2.1 Global Restriction Endonucleases Sales by Type (2020-2026)
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.2.5 Type IV
1.2.6 Others
1.3 Restriction Endonucleases Segment by Application
1.3.1 Global Restriction Endonucleases Sales Comparison by Application (2020-2026)
1.3.2 Academic & Research Institutes
1.3.3 Hospitals & Diagnostic Centers
1.3.4 Biopharmaceutical
1.3.5 Other
1.4 Restriction Endonucleases Market Estimates and Forecasts (2015-2026)
1.4.1 Global Restriction Endonucleases Sales Growth Rate (2015-2026)
1.4.2 Global Restriction Endonucleases Revenue and Growth Rate (2015-2026)
1.4.3 Global Restriction Endonucleases Price Trends (2015-2026)

2 Restriction Endonucleases Estimate and Forecast by Region
2.1 Global Restriction Endonucleases Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Restriction Endonucleases Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Restriction Endonucleases Sales Market Share by Region (2015-2020)
2.2.2 Global Restriction Endonucleases Revenue Market Share by Region (2015-2020)
2.3 Global Restriction Endonucleases Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Restriction Endonucleases Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Restriction Endonucleases Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Restriction Endonucleases Estimates and Projections (2015-2026)
2.4.2 Europe Restriction Endonucleases Estimates and Projections (2015-2026)
2.4.3 China Restriction Endonucleases Estimates and Projections (2015-2026)
2.4.4 Japan Restriction Endonucleases Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Restriction Endonucleases Estimates and Projections (2015-2026)
2.4.6 India Restriction Endonucleases Estimates and Projections (2015-2026)
3 Global Restriction Endonucleases Competition Landscape by Players
3.1 Global Top Restriction Endonucleases Players by Sales (2015-2020)
3.2 Global Top Restriction Endonucleases Players by Revenue (2015-2020)
3.3 Global Restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restriction Endonucleases as of 2019)
3.4 Global Restriction Endonucleases Average Price by Company (2015-2020)
3.5 Manufacturers Restriction Endonucleases Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Restriction Endonucleases Players (Opinion Leaders)
4 Global Restriction Endonucleases Market Size by Type
4.1 Global Restriction Endonucleases Historic Market Review by Type (2015-2020)
4.1.1 Global Restriction Endonucleases Sales Market Share by Type (2015-2020)
4.1.2 Global Restriction Endonucleases Revenue Market Share by Type (2015-2020)
4.1.3 Global Restriction Endonucleases Price by Type (2015-2020)
4.2 Global Restriction Endonucleases Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Restriction Endonucleases Sales Forecast by Type (2021-2026)
4.2.2 Global Restriction Endonucleases Revenue Forecast by Type (2021-2026)
4.2.3 Global Restriction Endonucleases Price Forecast by Type (2021-2026)
5 Global Restriction Endonucleases Market Size by Application
5.1 Global Restriction Endonucleases Historic Market Review by Application (2015-2020)
5.1.1 Global Restriction Endonucleases Sales Market Share by Application (2015-2020)
5.1.2 Global Restriction Endonucleases Revenue Market Share by Application (2015-2020)
5.1.3 Global Restriction Endonucleases Price by Application (2015-2020)
5.2 Global Restriction Endonucleases Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Restriction Endonucleases Sales Forecast by Application (2021-2026)
5.2.2 Global Restriction Endonucleases Revenue Forecast by Application (2021-2026)
5.2.3 Global Restriction Endonucleases Price Forecast by Application (2021-2026)

6 United States Restriction Endonucleases Market Facts & Figures
6.1 United States Restriction Endonucleases Sales Market Share by Company (2015-2020)
6.2 United States Restriction Endonucleases Sales Market Share by Type (2015-2020)
6.3 United States Restriction Endonucleases Sales Market Share by Application (2015-2020)

7 Europe Restriction Endonucleases Market Facts & Figures
7.1 Europe Restriction Endonucleases Sales Market Share by Company (2015-2020)
7.2 Europe Restriction Endonucleases Sales Market Share by Type (2015-2020)
7.3 Europe Restriction Endonucleases Sales Market Share by Application (2015-2020)

8 China Restriction Endonucleases Market Facts & Figures
8.1 China Restriction Endonucleases Sales Market Share by Company (2015-2020)
8.2 China Restriction Endonucleases Sales Market Share by Type (2015-2020)
8.3 China Restriction Endonucleases Sales Market Share by Application (2015-2020)

9 Japan Restriction Endonucleases Market Facts & Figures
9.1 Japan Restriction Endonucleases Sales Market Share by Company (3015-3030)
9.2 Japan Restriction Endonucleases Sales Market Share by Type (2015-2020)
9.3 Japan Restriction Endonucleases Sales Market Share by Application (2015-2020)

10 Southeast Asia Restriction Endonucleases Market Facts & Figures
10.1 Southeast Asia Restriction Endonucleases Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Restriction Endonucleases Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Restriction Endonucleases Sales Market Share by Application (2015-2020)

11 India Restriction Endonucleases Market Facts & Figures
11.1 India Restriction Endonucleases Sales Market Share by Company (2015-2020)
11.2 India Restriction Endonucleases Sales Market Share by Type (2015-2020)
11.3 India Restriction Endonucleases Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Restriction Endonucleases Business
12.1 New England Biolabs
12.1.1 New England Biolabs Corporation Information
12.1.2 New England Biolabs Business Overview
12.1.3 New England Biolabs Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.1.4 New England Biolabs Restriction Endonucleases Products Offered
12.1.5 New England Biolabs Recent Development
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Corporation Information
12.2.2 Thermo Fisher Scientific Business Overview
12.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Thermo Fisher Scientific Restriction Endonucleases Products Offered
12.2.5 Thermo Fisher Scientific Recent Development
12.3 Takara Bio
12.3.1 Takara Bio Corporation Information
12.3.2 Takara Bio Business Overview
12.3.3 Takara Bio Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Takara Bio Restriction Endonucleases Products Offered
12.3.5 Takara Bio Recent Development
12.4 Illumina
12.4.1 Illumina Corporation Information
12.4.2 Illumina Business Overview
12.4.3 Illumina Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Illumina Restriction Endonucleases Products Offered
12.4.5 Illumina Recent Development
12.5 Agilent Technologies
12.5.1 Agilent Technologies Corporation Information
12.5.2 Agilent Technologies Business Overview
12.5.3 Agilent Technologies Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Agilent Technologies Restriction Endonucleases Products Offered
12.5.5 Agilent Technologies Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Business Overview
12.6.3 Roche Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Roche Restriction Endonucleases Products Offered
12.6.5 Roche Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Corporation Information
12.7.2 GE Healthcare Business Overview
12.7.3 GE Healthcare Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GE Healthcare Restriction Endonucleases Products Offered
12.7.5 GE Healthcare Recent Development
12.8 Promega Corporation
12.8.1 Promega Corporation Corporation Information
12.8.2 Promega Corporation Business Overview
12.8.3 Promega Corporation Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Promega Corporation Restriction Endonucleases Products Offered
12.8.5 Promega Corporation Recent Development
12.9 Qiagen
12.9.1 Qiagen Corporation Information
12.9.2 Qiagen Business Overview
12.9.3 Qiagen Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Qiagen Restriction Endonucleases Products Offered
12.9.5 Qiagen Recent Development
12.10 Jena Biosciences
12.10.1 Jena Biosciences Corporation Information
12.10.2 Jena Biosciences Business Overview
12.10.3 Jena Biosciences Restriction Endonucleases Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Jena Biosciences Restriction Endonucleases Products Offered
12.10.5 Jena Biosciences Recent Development

13 Restriction Endonucleases Manufacturing Cost Analysis
13.1 Restriction Endonucleases Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Restriction Endonucleases
13.4 Restriction Endonucleases Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Restriction Endonucleases Distributors List
14.3 Restriction Endonucleases Customers

15 Market Dynamics
15.1 Restriction Endonucleases Market Trends
15.2 Restriction Endonucleases Opportunities and Drivers
15.3 Restriction Endonucleases Market Challenges
15.4 Restriction Endonucleases Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Restriction Endonucleases Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Restriction Endonucleases Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Restriction Endonucleases Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Restriction Endonucleases Sales (MT) by Region (2015-2020)
Table 5. Global Restriction Endonucleases Sales Market Share by Region (2015-2020)
Table 6. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Restriction Endonucleases Revenue Share by Region (2015-2020)
Table 8. Global Restriction Endonucleases Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Restriction Endonucleases Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Restriction Endonucleases Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Restriction Endonucleases Revenue Share Forecast by Region (2021-2026)
Table 12. Global Restriction Endonucleases (MT) of Key Companies (2015-2020)
Table 13. Global Restriction Endonucleases Sales Share by Company (2015-2020)
Table 14. Global Restriction Endonucleases Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Restriction Endonucleases Revenue Share by Company (2015-2020)
Table 16. Global Restriction Endonucleases by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restriction Endonucleases as of 2019)
Table 17. Global Restriction Endonucleases Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Restriction Endonucleases Manufacturing Sites and Area Served
Table 19. Manufacturers Restriction Endonucleases Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Restriction Endonucleases Players
Table 22. Global Restriction Endonucleases Sales (MT) by Type (2015-2020)
Table 23. Global Restriction Endonucleases Sales Share by Type (2015-2020)
Table 24. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Restriction Endonucleases Price (MT) by Type (2015-2020)
Table 26. Global Restriction Endonucleases Sales Share by Type (2021-2026)
Table 27. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Restriction Endonucleases Revenue Share by Type (2021-2026)
Table 29. Global Restriction Endonucleases Price (MT) by Type (2021-2026)
Table 30. Global Restriction Endonucleases Sales (MT) by Application (2015-2020)
Table 31. Global Restriction Endonucleases Sales Share by Application (2015-2020)
Table 32. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Restriction Endonucleases Price (MT) by Application (2015-2020)
Table 34. Global Restriction Endonucleases Sales (MT) by Application (2021-2026)
Table 35. Global Restriction Endonucleases Sales Share by Application (2021-2026)
Table 36. Global Restriction Endonucleases Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Restriction Endonucleases Revenue Share by Application (2021-2026)
Table 38. Global Restriction Endonucleases Price (MT) by Application (2021-2026)
Table 39. United States Restriction Endonucleases Sales (MT) by Company (2015-2020)
Table 40. United States Restriction Endonucleases Sales Market Share by Company (2015-2020)
Table 41. United States Restriction Endonucleases Sales (MT) by Type (2015-2020)
Table 42. United States Restriction Endonucleases Sales Market Share by Type (2015-2020)
Table 43. United States Restriction Endonucleases Sales (MT) by Application (2015-2020)
Table 44. United States Restriction Endonucleases Sales Market Share by Application (2015-2020)
Table 45. Europe Restriction Endonucleases Sales (MT) by Company (2015-2020)
Table 46. Europe Restriction Endonucleases Sales Market Share by Company (2015-2020)
Table 47. Europe Restriction Endonucleases Sales (MT) by Type (2015-2020)
Table 48. Europe Restriction Endonucleases Sales Market Share by Type (2015-2020)
Table 49. Europe Restriction Endonucleases Sales (MT) by Application (2015-2020)
Table 50. Europe Restriction Endonucleases Sales Market Share by Type (2015-2020)
Table 51. China Restriction Endonucleases Sales (MT) by Company (2015-2020)
Table 52. China Restriction Endonucleases Sales Market Share by Company (2015-2020)
Table 53. China Restriction Endonucleases Sales (MT) by Type (2015-2020)
Table 54. China Restriction Endonucleases Sales Market Share by Type (2015-2020)
Table 55. China Restriction Endonucleases Sales (MT) by Application (2015-2020)
Table 56. China Restriction Endonucleases Sales Market Share by Application (2015-2020)
Table 57. Japan Restriction Endonucleases Sales (MT) by Company (2015-2020)
Table 58. Japan Restriction Endonucleases Sales Market Share by Company (2015-2020)
Table 59. Japan Restriction Endonucleases Sales (MT) by Type (2015-2020)
Table 60. Japan Restriction Endonucleases Sales Market Share by Type (2015-2020)
Table 61. Japan Restriction Endonucleases Sales (MT) by Application (2015-2020)
Table 62. Japan Restriction Endonucleases Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Restriction Endonucleases Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Restriction Endonucleases Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Restriction Endonucleases Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Restriction Endonucleases Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Restriction Endonucleases Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Restriction Endonucleases Sales Market Share by Application (2015-2020)
Table 69. India Restriction Endonucleases Sales (MT) by Company (2015-2020)
Table 70. India Restriction Endonucleases Sales Market Share by Company (2015-2020)
Table 71. India Restriction Endonucleases Sales (MT) by Type (2015-2020)
Table 72. India Restriction Endonucleases Sales Market Share by Type (2015-2020)
Table 73. India Restriction Endonucleases Sales (MT) by Application (2015-2020)
Table 74. India Restriction Endonucleases Sales Market Share by Application (2015-2020)
Table 75. New England Biolabs Corporation Information
Table 76. New England Biolabs Description and Business Overview
Table 77. New England Biolabs Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. New England Biolabs Restriction Endonucleases Product
Table 79. New England Biolabs Recent Development
Table 80. Thermo Fisher Scientific Corporation Information
Table 81. Thermo Fisher Scientific Description and Business Overview
Table 82. Thermo Fisher Scientific Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Thermo Fisher Scientific Restriction Endonucleases Product
Table 84. Thermo Fisher Scientific Recent Development
Table 85. Takara Bio Corporation Information
Table 86. Takara Bio Description and Business Overview
Table 87. Takara Bio Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Takara Bio Restriction Endonucleases Product
Table 89. Takara Bio Recent Development
Table 90. Illumina Corporation Information
Table 91. Illumina Description and Business Overview
Table 92. Illumina Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Illumina Restriction Endonucleases Product
Table 94. Illumina Recent Development
Table 95. Agilent Technologies Corporation Information
Table 96. Agilent Technologies Description and Business Overview
Table 97. Agilent Technologies Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Agilent Technologies Restriction Endonucleases Product
Table 99. Agilent Technologies Recent Development
Table 100. Roche Corporation Information
Table 101. Roche Description and Business Overview
Table 102. Roche Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Roche Restriction Endonucleases Product
Table 104. Roche Recent Development
Table 105. GE Healthcare Corporation Information
Table 106. GE Healthcare Description and Business Overview
Table 107. GE Healthcare Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. GE Healthcare Restriction Endonucleases Product
Table 109. GE Healthcare Recent Development
Table 110. Promega Corporation Corporation Information
Table 111. Promega Corporation Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Promega Corporation Description and Business Overview
Table 113. Promega Corporation Restriction Endonucleases Product
Table 114. Promega Corporation Recent Development
Table 115. Qiagen Corporation Information
Table 116. Qiagen Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Qiagen Description and Business Overview
Table 118. Qiagen Restriction Endonucleases Product
Table 119. Qiagen Recent Development
Table 120. Jena Biosciences Corporation Information
Table 121. Jena Biosciences Description and Business Overview
Table 122. Jena Biosciences Restriction Endonucleases Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Jena Biosciences Restriction Endonucleases Product
Table 124. Jena Biosciences Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Restriction Endonucleases Distributors List
Table 128. Restriction Endonucleases Customers List
Table 129. Restriction Endonucleases Market Key Trends
Table 130. Restriction Endonucleases Key Opportunities and Drivers
Table 131. Restriction Endonucleases Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Restriction Endonucleases Product Picture
Figure 2. Global Restriction Endonucleases Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Restriction Endonucleases Market Share by Application in 2020 & 2026
Figure 6. Academic & Research Institutes Examples
Figure 7. Hospitals & Diagnostic Centers Examples
Figure 8. Biopharmaceutical Examples
Figure 9. Other Examples
Figure 10. Global Restriction Endonucleases Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Restriction Endonucleases Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Restriction Endonucleases Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Restriction Endonucleases Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Restriction Endonucleases Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Restriction Endonucleases Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Restriction Endonucleases Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Restriction Endonucleases Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Restriction Endonucleases Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Restriction Endonucleases Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Restriction Endonucleases Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Restriction Endonucleases Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Restriction Endonucleases Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Restriction Endonucleases Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Restriction Endonucleases Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Restriction Endonucleases Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Restriction Endonucleases Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Restriction Endonucleases Players Market Share by Revenue in Restriction Endonucleases 2015 & 2019
Figure 28. Restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Restriction Endonucleases Revenue Share by Type (2015-2020)
Figure 30. Global Restriction Endonucleases Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Restriction Endonucleases Revenue Share by Application (2015-2020)
Figure 32. Global Restriction Endonucleases Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Restriction Endonucleases Sales Market Share by Type in 2019
Figure 34. United States Restriction Endonucleases Sales Market Share by Type in 2019
Figure 35. Europe Restriction Endonucleases Sales Market Share by Company in 2019
Figure 36. Europe Restriction Endonucleases Sales Market Share by Type in 2019
Figure 37. Europe Restriction Endonucleases Sales Market Share by Application in 2019
Figure 38. China Restriction Endonucleases Sales Market Share by Company in 2019
Figure 39. China Restriction Endonucleases Sales Market Share by Type in 2019
Figure 40. China Restriction Endonucleases Sales Market Share by Application in 2019
Figure 41. Japan Restriction Endonucleases Sales Market Share by Company in 2019
Figure 42. Japan Restriction Endonucleases Sales Market Share by Type in 2019
Figure 43. Japan Restriction Endonucleases Sales Market Share by Application in 2019
Figure 44. Southeast Asia Restriction Endonucleases Sales Market Share by Company in 2019
Figure 45. Southeast Asia Restriction Endonucleases Sales Market Share by Type in 2019
Figure 46. Southeast Asia Restriction Endonucleases Sales Market Share by Application in 2019
Figure 47. India Restriction Endonucleases Sales Market Share by Company in 2019
Figure 48. India Restriction Endonucleases Sales Market Share by Type in 2019
Figure 49. India Restriction Endonucleases Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Restriction Endonucleases
Figure 52. Manufacturing Process Analysis of Restriction Endonucleases
Figure 53. Restriction Endonucleases Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


【掲載企業】

New England Biolabs、Thermo Fisher Scientific、Takara Bio、Illumina、Agilent Technologies、Roche、GE Healthcare、Promega Corporation、Qiagen、Jena Biosciences

★調査レポート[世界の制限エンドヌクレアーゼ市場レポート2020年] (コード:QYR21FB12322)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の制限エンドヌクレアーゼ市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆